<DOC>
	<DOCNO>NCT02379195</DOCNO>
	<brief_summary>Adoptive T cell therapy tumor infiltrate lymphocyte ( TIL ) achieve impressive clinical result durable complete response patient metastatic melanoma . The TILs isolate patient tumor tissue follow vitro expansion activation around 4-6 week . Before TIL infusion patient receive 1 week precondition chemotherapy cyclophosphamide fludarabine . After TIL infusion Interleukin-2 administer support T cell activation proliferation vivo . In trial therapy combine peginterferon ( pegylated form interferon alpha 2b ) . Interferon alpha immunomodulatory effect know upregulate HLA expression melanoma cell hypothesize synergize TIL therapy .</brief_summary>
	<brief_title>Peginterferon TIL Therapy Metastatic Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<criteria>Histologically confirm unresectable stage III stage IV metastatic melanoma Metastasis available surgical resection ( 2 cm3 ) residual measurable disease resection ECOG performance status 01 Life expectancy ≥ 3 month No significant toxicity prior treatment Adequate renal , hepatic hematologic function Women childbearing potential ( WOCBP ) men sexual relationship WOCBP must use effective method contraception treatment least 6 month completion af treatment . Able comprehend information give willing sign inform consent Other Malignancies , unless follow ≥ 5 year sign disease , except squamous cell carcinoma adequately treat carcinoma situ colli uterus . Cerebral metastasis . Patients previously treat CNS metastasis participate CNS metastasis surgically remove treated stereotactic radiosurgery stable ≥ 28 day treatment measure MRI . Patients asymptomatic , stable untreated CNS metastasis include accord investigator sponsor decision . Patients ocular melanoma Severe allergy , history anaphylaxis know allergy administer drug . Serious medical psychiatric comorbidity Creatinine clearance &lt; 70 ml/min Acute chronic infection e.g . HIV , hepatitis , tuberculosis Severe active autoimmune disease Pregnant nursing woman Need immunosuppressive treatment , e.g . corticosteroid methotrexate Concomitant treatment experimental drug Patients uncontrolled hypercalcemia Less four week since prior systemic antineoplastic treatment time treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>